The New York Genome Center (NYGC) is an independent, nonprofit academic research institution that serves as a multi-institutional hub for genomic research. Leveraging our strengths in whole-genome sequencing and genomic analysis, our mission is the advancement of genomic science and its application to drive novel biomedical discoveries. NYGC’s areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease. In 2020, the NYGC also has directed its expertise to COVID-19 research.

We are committed to prioritizing diversity, equity, and inclusion, which is fundamental to promoting greater collaboration, innovation, and discovery. Learn more about NYGC’s Commitment to Diversity, Equity, and Inclusion.

medRxiv. 2021 Jan. 8.

Host genome analysis of structural variations by Optical Genome Mapping provides clinically valuable insights into genes implicated in critical immune, viral infection, and viral replication pathways in patients with severe COVID-19.

Nikhil Shri Sahajpal, Chi-Yu Jill Lai, Alex Hastie, Ashis K Mondal, Siavash Raeisi Dehkordi, Cas van der Made, Olivier Fedrigo, Farooq Al-Ajli, Sawan Jalnapurkar, Rashmi Kanagal-Shamanna, Brynn Levy, Silviu-Alin Bacanu, Michael C Zody, Catherine A. Brownstein, Amyn M. Rojiani, Alan H. Beggs, Vineet Bafna, Alexander Hoischen, Erich D. Jarvis, Alka Chaubey, Ravindra Kolhe, COVID-19 Host Genome Structural Variation Consortium

Institutional Founding Members

Institutional Associate Members